Advertisement

Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors
Posted: 09/12/2023 | By: Sarah Campen, PharmD

Bright et al reviewed interventions to enhance adjuvant endocrine therapy adherence and identified strengths and limitations of existing interventions to inform future research and clinical care. Their findings were published in the Journal of Clinical Oncology.

Question 1 of 5

Which statement regarding the use of adjuvant endocrine therapy in hormone receptor–positive breast tumors is FALSE?

Choose 1

A
30% of patients take the medication less frequently than directed
B
Adjuvant endocrine therapy is typically prescribed for 5 to 10 years
C
Up to 40% of patients discontinue adjuvant endocrine therapy early
D
Hormone receptor–positive breast tumors account for approximately 38% of breast cancer cases in the United States

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage